Methylphenidate extended-release chewable tablets - Tris Pharma
At a glance
- Drug Originator NextWave Pharmaceuticals
- Drug Licenced by KYE Pharmaceuticals; Neuraxpharm; Pediatrix Therapeutics
- Drug Class Behavioural disorder therapies; Neuroprotectants; Nootropics; Phenylacetates; Piperidines; Sleep disorder therapies; Small molecules
- Mechanism of Action Central nervous system stimulants; Dopamine uptake inhibitors; Monoamine oxidase inhibitors
- USA Patent Applicants NEXTWAVE PHARMS
- USA Patents 19
- NDAs 1
- International Patents 38
- Patent Applications 3,514

Disclaimer